MAP2K7 and acute lymphoblastic leukemia: Expressing specific mutant and/or wild-type IL7R signaling molecules in two steroid-sensitive T-ALL cell lines induced steroid resistance via robust downstream signaling through MEK-ERK and AKT, thereby reducing steroid-induced apoptosis.